Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Express Scripts
McKesson
Johnson and Johnson
Mallinckrodt
Moodys
Dow

Last Updated: December 11, 2019

DrugPatentWatch Database Preview

Ranitidine - Generic Drug Details

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What are the generic drug sources for ranitidine and what is the scope of patent protection?

Ranitidine is the generic ingredient in nine branded drugs marketed by Novitium Pharma, Glaxosmithkline, Ajanta Pharma Ltd, Appco Pharma Llc, Aurobindo Pharma Ltd, Dr Reddys Labs Ltd, Mylan, Sandoz, Teva, Glaxo Grp Ltd, Bedford, Mylan Labs Ltd, West-ward Pharms Int, Zydus Pharms Usa Inc, Teligent, Actavis Mid Atlantic, Amneal Pharms, Anda Repository, Apotex Inc, Breckenridge, Hi Tech Pharma, Lannett Co Inc, Nostrum Labs Inc, Pharm Assoc, Ranbaxy, Taro, Torrent, Wockhardt, Sanofi Us, Acic Pharms, Amneal Pharms Ny, Ani Pharms Inc, Apotex, Boehringer Ingelheim, Contract Pharmacal, Dr Reddys Labs Inc, Glenmark Pharms Inc, Granules India Ltd, Heritage Pharma, Par Pharm, Perrigo, Perrigo R And D, Strides Pharma, Sun Pharm Inds Ltd, Unique Pharm Labs, Vkt Pharma Pvt Ltd, Watson Labs, and Wockhardt Ltd, and is included in eighty-five NDAs. Additional information is available in the individual branded drug profile pages.

There are forty-three drug master file entries for ranitidine. Two suppliers are listed for this compound. There is one tentative approval for this compound.

Drug Prices for ranitidine

See drug prices for ranitidine

Drug Sales Revenue Trends for ranitidine

See drug sales revenues for ranitidine

Recent Clinical Trials for ranitidine

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
B.P. Koirala Institute of Health SciencesPhase 4
Ain Shams UniversityN/A
University of Sao Paulo General HospitalN/A

See all ranitidine clinical trials

Generic filers with tentative approvals for RANITIDINE
Applicant Application No. Strength Dosage Form
  Start Trial  Start Trial15MG/MLSolution; Oral

The 'tentative' approval signifies that the product meets all FDA standards for marketing, and, but for the patents / regulatory protections, it would approved.

Pharmacology for ranitidine
Synonyms for ranitidine
({5-[(2-{[(1E)-1-(methylamino)-2-nitrovinyl]amino}ethylthio)methyl](2-furyl)}m ethyl)dimethylamine
(E)-1-N'-[2-[[5-(dimethylaminomethyl)furan-2-yl]methylsulfanyl]ethyl]-1-N-methyl-2-nitroethene-1,1-diamine
(E)-N-(2-(((5-((Dimethylamino)methyl)furan-2-yl)methyl)thio)ethyl)-N-methyl-2-nitroethene-1,1-diamine
(E)-N-(2-((5-((dimethylamino)methyl)furan-2-yl)methylthio)ethyl)-N-methyl-2-nitroethene-1,1-diamine
(E)-N-{2-[({5-[(dimethylamino)methyl]-2-furyl}methyl)sulfanyl]ethyl}-N'-methyl-2-nitroethene-1,1-diamine
(E)-N-{2-[({5-[(dimethylamino)methyl]furan-2-yl}methyl)sulfanyl]ethyl}-N'-methyl-2-nitroethene-1,1-diamine
(E)-N1'-[2-[[5-(dimethylaminomethyl)-2-furyl]methylsulfanyl]ethyl]-N1-methyl-2-nitro-ethene-1,1-diamine
(E)-N1'-[2-[[5-[(dimethylamino)methyl]-2-furanyl]methylthio]ethyl]-N1-methyl-2-nitroethene-1,1-diamine
(E)-N1'-[2-[[5-[(dimethylamino)methyl]furan-2-yl]methylsulfanyl]ethyl]-N1-methyl-2-nitro-ethene-1,1-diamine
1,1-Ethenediamine, N-(2-(((5-((dimethylamino)methyl)-2-furanyl)methyl)thio)ethyl)-N'-methyl-2-nitro-
1,1-Ethenediamine, N-[2-[[[5-[(dimethylamino)methyl]-2-furanyl]methyl]thio]ethyl]-N'-methyl-2-nitro-
1,1-Ethenediamine, N-[2-[[[5-[(dimethylamino)methyl]-2-furanyl]methyl]thio]ethyl]-N'-methyl-2-nitro-, (E)-
357R355
66357-35-5
A835434
AB00052223_11
AB00052223_12
AB00052223-10
AB1009310
AC-12712
AC1MHDJB
AC1Q1WQX
Achedos
Acidex
AH-19065
AKOS005552967
Alquen
Alter-H2
Alvidina
API0004039
Apo-Ranitidin
Artomil
Atural
Axoban
Azuranit
BCP21325
BDBM22893
BDBM237183
BIDD:GT0179
Biotidin
BRD-K70505054-001-02-9
C13H22N4O3S
CAS-66357-35-5
CAS-66357-59-3
CCG-39025
CHEBI:8776
CHEBI:92246
CHEMBL512
Coralen
D00422
D0B8WN
DB00863
Digestosan
dimethyl[(5-{[(2-{[(E)-1-(methylamino)-2-nitroethenyl]amino}ethyl)sulfanyl]methyl}furan-2-yl)methyl]amine
DSSTox_CID_25191
DSSTox_GSID_45191
DSSTox_RID_80738
Duractin
EINECS 266-332-5
Epitope ID:127515
Ergan
Esofex
Ezopta
Fendibina
Gastrial
Gastridina
Gastrolav
Gastrosedol
Gavilast
GTPL1234
HMS1921L07
HMS2092H15
HMS501F22
HSDB 3925
I09-0405
IDI1_000440
Istomar
J10378
KB-80331
KS-5230
Kuracid
L000504
Label
Lake
Logast
Logat
Lopac-R-101
Lopac0_001073
LS-67645
Mauran
Melfax
Microtid
Mideran
MolPort-003-666-370
MolPort-044-723-992
N (2-(((5-((Dimethylamino)methyl)-2-furanyl)methyl)thio)ethyl)-N'-methyl-2-nitro-1,1-ethenediamine
N-(2-((5-((Dimethylamino)methyl)furfuryl)thio)ethyl)-N'-methyl-2-nitro-1,1-ethenediamine
N-[(E)-1-(Methylamino)-2-nitroethenyl]-2-[[[2-[(dimethylamino)methyl]-5-furanyl]methyl]thio]ethanamine
N-[2-[[5-(dimethylaminomethyl)furan-2-yl]methylsulfanyl]ethyl]-N'-methyl-2-nitroethene-1,1-diamine
N-[2-[[5-[(Dimethylamino)methyl]furfuryl]thio]ethyl]-N'-methyl-2-nitro-1,1-ethenediamine
N-[2-[[5-[(Dimethylamino)methyl]furfuryl]thio]ethyl]-N'-methyl-2-nitro-1,1-ethylenediamine
N'-[2-[[5-(Dimethylaminomethyl)-2-furyl]methylsulfanyl]ethyl]-N-methyl-2-nitro-ethene-1,1-diamine hydrochloride
N1'-[2-[[5-[(dimethylamino)methyl]-2-furanyl]methylthio]ethyl]-N1-methyl-2-nitroethene-1,1-diamine
NCGC00015876-01
NCGC00015876-02
NCGC00015876-03
NCGC00015876-04
NCGC00015876-05
NCGC00015876-06
NCGC00015876-07
NCGC00015876-08
NCGC00015876-09
NCGC00015876-11
NCGC00018108-01
NCGC00018108-02
NCGC00018108-03
NCGC00024387-02
NCGC00094913-01
NCGC00094913-02
NCGC00094913-03
NCGC00094913-04
NCGC00094913-05
NCGC00256269-01
Neugal
Noktome
Normon
Novo-Radinine
NSC-757851
NSC757851
Nu-Ranit
Pep-Rani
Pharmakon1600-01501151
Prestwick2_000201
Ptinolin
Quadrin
Quantor
Quicran
Radin
Radinat
RAN
Ran H2
Ran Lich
Randin
Rani 2
Rani AbZ
Rani-BASF
Rani-nerton
Rani-Puren
Rani-Q
Rani-Sanorania
Raniben
Raniberl
Raniberta
Ranibloc
ranic
Ranicux
Ranidil
Ranidin
Ranidine
Ranidura
Ranifur
Ranigasan
Ranigast
Ranigen
Ranilonga
Ranimerck
Ranin
Raniogas
Raniplex
Ranisan
Ranisen
Ranitab
Raniter
Ranitic
Ranitidin
Ranitidin 1A Pharma
Ranitidin AL
Ranitidin Arcana
Ranitidin Atid
Ranitidin AWD
Ranitidin Basics
Ranitidin Duncan
Ranitidin Dyna
Ranitidin Helvepharm
Ranitidin Heumann
Ranitidin Hexal
Ranitidin Merck
Ranitidin Millet
Ranitidin NM
Ranitidin Normon
Ranitidin PB
Ranitidin Stada
Ranitidin von ct
Ranitidin-Cophar
Ranitidin-Isis
Ranitidin-ratiopharm
Ranitidina
Ranitidina [INN-Spanish]
Ranitidina predilu Grif
Ranitidina Tamarang
Ranitidine (Form I And Form Ii)
Ranitidine (TN)
Ranitidine (USAN/INN)
Ranitidine [USAN:BAN:INN]
Ranitidine Base
Ranitidine HCL
Ranitidine HCL 1/2 Type
ranitidine.hcl
Ranitidinum
Ranitidinum [INN-Latin]
Ranitiget
Ranitin
Ranitine
Ranobel
Rantacid
Rantidine
Ranuber
Ratic
Raticina
Regalil
Renatac
RND
Rozon
Rubiulcer
Sampep
Santanol
SBB006527
SBI-0051043.P003
SC-45877
Serviradine
Sostril
SPECTRUM1501151
Spectrum5_001189
SR-01000075288
SR-01000075288-3
ST050299
STK619092
Tanidina
Taural
Terposen
Tocris-1967
Toriol
Tox21_110250
Tox21_110250_1
Tox21_302372
Ul-Pep
Ulcecur
Ulceranin
Ulcex
Ulcirex
Ulcodin
Ulcolind Rani
Ulsaven
Ultidine
Urantac
Verlost
Vesyca
Viserul
Vizerul
VMXUWOKSQNHOCA-UKTHLTGXSA-N
Weichilin
Weidos
Xanidine
Zandid
Zantab
ZANTAC
Zantac (TN)
Zantac 150
Zantac 75
Zantac In Plastic Container
Zantadin
Zantarac
Zantic
ZINC1530728

US Patents and Regulatory Information for ranitidine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glaxo Grp Ltd ZANTAC 150 ranitidine hydrochloride GRANULE, EFFERVESCENT;ORAL 020251-002 Mar 31, 1994 DISCN No No   Start Trial   Start Trial   Start Trial
Watson Labs RANITIDINE HYDROCHLORIDE ranitidine hydrochloride TABLET;ORAL 074864-001 Oct 20, 1997 DISCN No No   Start Trial   Start Trial   Start Trial
Glaxo Grp Ltd ZANTAC 300 ranitidine hydrochloride TABLET;ORAL 018703-002 Dec 9, 1985 DISCN Yes No   Start Trial   Start Trial   Start Trial
Perrigo R And D RANITIDINE HYDROCHLORIDE ranitidine hydrochloride TABLET;ORAL 091429-001 May 11, 2011 OTC No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Colorcon
McKinsey
Medtronic
Dow
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.